Derayah Financial Begins Jamjoom Pharmaceuticals' Coverage at Buy

MT Newswires · 1d ago
08:35 AM EDT, 10/14/2026 (MT Newswires) -- Derayah Financial on Tuesday started its coverage of pharmaceutical company Jamjoom Pharmaceuticals Factory Co. (SASE:4015) with a buy rating and a price target of 150.00 Saudi riyals. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)